Pharmakokinetik von Antihypertensiva bei Niereninsuffizienz

作者: K. H. Rahn

DOI: 10.1007/978-3-642-67676-5_9

关键词:

摘要: Es ist nicht uberraschend, das bei Niereninsuffizienz die renale Elimination der Arzneimittel, normalerweise zu einem bedeutsamen Teil uber Nieren ausgeschieden werden, abnimmt. Das gilt auch fur Antihypertensiva.

参考文章(15)
TB Tjandramaga, R Verbeeck, J Thomas, R Verbesselt, R Verberckmoes, PJD Schepper, The effect of end-stage renal failure and haemodialysis on the elimination kinetics of sotalol. British Journal of Clinical Pharmacology. ,vol. 3, pp. 259- 265 ,(1976) , 10.1111/J.1365-2125.1976.TB00601.X
F. D. Thompson, A. M. Joekes, D. M. Foulkes, Pharmacodynamics of propranolol in renal failure. BMJ. ,vol. 2, pp. 434- 436 ,(1972) , 10.1136/BMJ.2.5811.434
L. MAÎTRE, M. STAEHELIN, H. BRUNNER, Antihypertensive and noradrenaline-depleting effects of guanethidine metabolites. Journal of Pharmacy and Pharmacology. ,vol. 23, pp. 327- 331 ,(2011) , 10.1111/J.2042-7158.1971.TB09922.X
S. �ie, G. Levy, Relationship between renal function and elimination kinetics of pindolol in man. European Journal of Clinical Pharmacology. ,vol. 9, pp. 115- 116 ,(1975) , 10.1007/BF00614006
K. Schrader, H. Brass, D. Renner, Zur Pharmakokinetik von α-Methyldopa bei Niereninsuffizienz Journal of Molecular Medicine. ,vol. 49, pp. 1329- 1334 ,(1971) , 10.1007/BF01495520
Thomas T. Zsotér, Gordon E. Johnson, George A. DeVeber, Hindy Paul, Excretion and metabolism of reserpine in renal failure. Clinical Pharmacology & Therapeutics. ,vol. 14, pp. 325- 330 ,(1973) , 10.1002/CPT1973143325
J McAinsh, Clinical pharmacokinetics of atenolol. Postgraduate Medical Journal. pp. 74- 78 ,(1977)
Chia M. Huang, Arthur J. Atkinson, Murray Levin, Nathan W. Levin, Antonio Quintanilla, Pharmacokinetics of furosemide in advanced renal failure. Clinical Pharmacology & Therapeutics. ,vol. 16, pp. 659- 666 ,(1974) , 10.1002/CPT1974164659